New York State Common Retirement Fund
LXEO icon

New York State Common Retirement Fund’s Lexeo Therapeutics LXEO Stock Holding History

New York State Common Retirement Fund’s Portfolio LXEO Stock Details LXEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$92.6K Hold
19,887
– – ﹤0.01% 2740
2026
Q1 		$114K Hold
19,887
– – ﹤0.01% 2463
2025
Q4 		$197K Buy
19,887
+15,700
+375% +$143K ﹤0.01% 2306
2025
Q3 		$27.8K Hold
4,187
– – ﹤0.01% 3067
2025
Q2 		$16.8K Hold
4,187
– – ﹤0.01% 3130
2025
Q1 		$14.5K Hold
4,187
– – ﹤0.01% 3025
2024
Q4 		$27.6K Hold
4,187
– – ﹤0.01% 2991
2024
Q3 		$37.9K Hold
4,187
– – ﹤0.01% 2940
2024
Q2 		$67.2K Buy
4,187
+87
+2% +$1.26K ﹤0.01% 3010
2024
Q1 		$64.3K Buy
+4,100
New +$64.1K ﹤0.01% 2901

Other funds holding LXEO

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

New York State Common Retirement Fund's LXEO Position: Q2 2026 in Review

New York State Common Retirement Fund held its Lexeo Therapeutics (LXEO) position steady in Q2 2026 at 19,887 shares worth $92.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2740.

New York State Common Retirement Fund first reported a position in LXEO in Q1 2024 and has held it in 10 quarters since. The position peaked at $197K in Q4 2025. 141 funds tracked by Wall St. Rank hold LXEO as of Q2 2026.

  • New York State Common Retirement Fund held 19,887 shares of Lexeo Therapeutics worth $92.6K as of Q2 2026.
  • New York State Common Retirement Fund left its Lexeo Therapeutics share count unchanged in Q2 2026.
  • Lexeo Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2740 holding.
  • New York State Common Retirement Fund first reported a position in Lexeo Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • New York State Common Retirement Fund's Lexeo Therapeutics position peaked at $197K in Q4 2025.
  • 141 funds tracked by Wall St. Rank held Lexeo Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.